Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel

Multiple Sclerosis

Volumn 5, Issue 6, 1999, Pages 410-415

  Karni, A ^a,e   Kohn, Y ^a   Safirman, C ^a   Abramsky, O ^a   Barcellos, L ^b   Oksenberg, J R ^b   Kahana, E ^c   Karussis, D ^a   Chapman, J ^d   Brautbar, C ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BARZILAI MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

Association study; GENEHUNTER; Human leukocyte antigens (HLA); Linkage analysis; Major histocompatibility complex (MHC); Multiple sclerosis (MS)

Indexed keywords

HLA ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME 6P; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; ISRAEL; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTIPLE SCLEROSIS; RELATIVE;

EID: 0033382073     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245899678846438     Document Type: Article

References (33)

1. Ebers GC, Sadovnick AD. (1994) The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol 54: 1-17.
2. Ebers GC, Sadovnick AD, Risch NJ. (1995) A genetic basis for familial aggregation in multiple sclerosis. The Canadian Collaborative Study Group. Nature 377: 150-151.
3. Olerup O, Hillert J. (1991) HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 38: 1-15.
4. Kelly MA et al. (1993) The influence of HLA-DR and -DQ alleles on progression to multiple sclerosis following a clinically isolated syndrome. Hum Immunol 37: 185-191.
5. Ghabanbasani MZ et al. (1995) Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DRβ1 chain in multiple sclerosis. J Neuroimmunol 59: 77-82.
6. Marrosu MG et al. (1992) HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1*0201 and *0302 alleles. Neurology 42: 883-886.
7. Gorodezky C et al. (1986) Immunogenetic profile of multiple sclerosis in Mexicans. Hum Immunol 16: 364-374.
8. Kwon OJ et al. (1999) HLA class II susceptibility to multiple sclerosis in Ashkenazi and non-Ashkenazi Jews. Arch Neurol 56: 555-560.
9. Sawcer S et al. (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 13: 464-468.
10. The Multiple Sclerosis Genetics Group. (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genet 13: 469-471.
11. Ebers GC et al. (1982) HLA typing in sibling pairs with multiple sclerosis. Lancet 2: 1278.
12. Francis DA et al. (1987) HLA genetic determinants in familial MS. A study from the Grampian region of Scotland. Tissue Antigens 29: 7-12.
13. Tienari PJ et al. (1994) Two-locus linkage analysis in multiple sclerosis (MS). Genomics 19: 320-325.
14. Kellar-Wood HF et al. (1995) Multiple sclerosis and the HLA-D region: linkage and association studies. J Neuroimmunol 58: 183-190.
15. Eoli M et al. (1995) Evidence of linkage between susceptibility to multiple sclerosis and HLA-class II loci in Italian multiplex families. Eur J Human Genet 3: 303-311.
16. Fogdell A et al. (1997) Linkage analysis of HLA class II genes in Swedish multiplex families with multiple sclerosis. Neurology 48: 758-762.
17. Martin M et al. (1998) Characterization of 12 microsatellite loci of human MHC in a panel of reference cell lines. Immunogenetics 47: 131-138.
18. Lander ES, Schork NJ. (1994) Genetic dissection of complex traits. Science 265: 2037-2045.
19. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. (1996) Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 58: 1347-1363.
20. Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227-231.
21. Goodkin DE et al. (1991) Diagnostic criteria for multiple sclerosis research involving multiply affected families. Arch Neurol 48: 805-807.
22. Miller SA, Dykes DD, Polesky HF. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
23. Kimura A, Sasazuki T. (1992) Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In Tsuji K, Aizawa M, Sasazuki, T (eds). HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference, Vol 1. Oxford University Press: Oxford, pp 397-419.
24. Bodmer JG et al. (1997) Nomenclature for factors of the HLA system, 1996. Tissue Antigens 49: pp. 297-321.
25. Gallager G, Eskdale J, Miller S. (1997) A highly polymorphic microsatellite marker in the human MHC class III region, close to the Bat2 gene. Immunogenetics 46: 357-358.
26. Orphanos V, McGown G, Boyle JM, Santibanez-Koref M. (1993) Thirteen dinucleotide repeat polymorphisms on chromosome 6. Hum Mol Genet 2: 2196.
27. Hudson TJ, Clark CD, Gschwend CE, Justice-Higgins E. (1998) Unit 2.5: PCR methods of genotyping. In Dracopoli NC, Haines JL, Korf BR, Norton CC, Seidman CE, Seidman JG, Moir DT, Smith DR (eds). Current Protocols in Human Genetics. John Wiley & Sons, New York.
28. 2 test. J Roy Stat Soc Suppl 1: 217-235.
29. Irwin JO. (1935) Tests of significance for differences between percentages based on small numbers. Metron 12: 83-94.
30. Spielman RS, McGinnis RE, Ewens WJ. (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52: 506-516.
31. Kahana E et al. (1994) Multiple Sclerosis: genetic versus environmental aetiology. Epidemiology in Israel updated. J Neurol 241: 341-346.
32. The multiple sclerosis genetics group. (1998) Linkage of the MHC to familial multiple sclerosis suggest genetic heterogeneity. Hum Mol Genet 7: 1229-1234.
33. Roitberg-Tambur A et al. (1995) Comparative analysis of HLA polymorphism at the serologic and molecular level in Moroccan and Ashkenazi Jews. Tissue Antigens 46: 104-110.